Create your page here
Latest News for: bicyclic molecule
Edit
UCLA Chemists Challenge A 100-Year Rule That May Change The Face Of Pharma Industry
News18 03 Nov 2024
For a long time, scientists thought molecules could not have a carbon-carbon double bond at the bridge spot of a bicyclic molecule. This idea is called Bredt’s rule and it’s been in textbooks since 1924 ... .
Edit
US chemists debunk 100-year-old Bredt’s Rule to change organic chemistry forever
Interesting Engineering 31 Oct 2024
“Molecules cannot have a carbon-carbon double bond at the ring junction of a bridged bicyclic molecule,” as stated in a press release ... Double bonds can’t occur at certain positions on organic molecules ...
Edit
The Eagle-Tribune
28 Feb 2024
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
The Eagle-Tribune
28 Feb 2024
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ® molecules, for diseases that are underserved by existing therapeutics.
Edit
The Eagle-Tribune
20 Feb 2024
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
The Eagle-Tribune
20 Feb 2024
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ® molecules, for diseases that are underserved by existing therapeutics.
Edit
The Eagle-Tribune
07 Feb 2024
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
The Eagle-Tribune
07 Feb 2024
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle ® molecules, for diseases that are underserved by existing therapeutics.
Edit
The Eagle-Tribune
14 Dec 2023
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
The Eagle-Tribune
14 Dec 2023
“In totality, the data support the emerging differentiated profile of our Bicycle ® molecules, paving the way to deliver best-in-class or first-in-class therapies for many cancers ... Bicycle ® molecules.
Edit
The Eagle-Tribune
30 Nov 2023
Bicycle Therapeutics to Host R&D Day on December 14
The Eagle-Tribune
30 Nov 2023
The company will also highlight the broad capabilities of its novel Bicycle ® platform technology ... Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry.
Edit
The Eagle-Tribune
02 Nov 2023
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming ...
The Eagle-Tribune
02 Nov 2023
Edit
Heidelberg Pharma Presents New Clinical Data from its Lead Candidate HDP-101 at the ASH Annual Meeting 2023
Pharmiweb 02 Nov 2023
... specificity of antibodies with the efficacy of small toxic molecules to fight cancer ... Amanitin belongs to the amatoxin molecules, bicyclic peptides that occur naturally in the green deathcap mushroom.
Edit
Tyler Morning Telegraph
19 Oct 2023
Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 ...
Tyler Morning Telegraph
19 Oct 2023
Edit
Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer
Pharmiweb 11 Sep 2023
Edit
Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Pharmiweb 05 Sep 2023
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics (NASDAQ ... Bicycles are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry ... [email protected].
Edit
Optimizing molecular photoswitches for solar energy harvesting
Phys Dot Org 30 Aug 2023
They studied molecules known as bicyclic dienes, which switch to a high-energy state when illuminated ... the bicyclic part, allowed the new molecules to store more energy than the original norbornadiene.
Edit
Heidelberg Pharma AG: Heidelberg Pharma’s Partner Takeda Reached Development Milestone
Pharmiweb 08 Aug 2023
... antibodies with the potency of cytotoxic small molecules for the treatment of cancer ... Amanitin belongs to the amatoxin molecules, bicyclic peptides that occur naturally in the green deathcap mushroom.
- 1
- 2
- Next page »